The payments under the temporary financial arrangements will be subject to adjustment for the reduction in variable costs. The NHS has yet to give a figure for the reduction, or explained the mechanism for reclaiming the reduction – i.e. whether by a lump sum or reductions to future payments. This has left businesses in a difficult position, as variable costs are typically to be shared with the associates. With these not being known at this stage, businesses have a choice either to reduce the monies paid to their associates with a view to topping it up later, or pay the normal UDA rate and then seek to reclaim monies from the associates later. The former approach arguably does not honour the NHS's requirement that associates be paid 'at previous levels', whereas the latter approach carries commercial risk if the associate chooses to leave before the money has been fully clawed back.
Businesses do not yet know what activity they will be expected to perform over the 2020/21 financial year. If we assume a dental business has a contract for 12,000 UDAs, and the measures last until the end of June, you could sensibly argue for two different targets for the remainder of the year:
- If performance is assessed over the full year, their target is 12,000 UDAs. Businesses will already be deemed to have done 3,000 UDAs, so will have to do a further 8,520 to meet the 96% target of 11,520 UDAs;
- If performance is assessed over the remainder of the year, that being July 2020 to April 2021, the target for that period is 9,000 UDAs. Businesses will have to do 8,640 UDAs to meet the 96% target.
The NHS has not stated if and how clawback and/or breach notices will operate for 2020/21. This will be particularly important if patients are slow to return to their dentists for routine check-ups.
For mixed and private dental businesses
The NHS clarified that mixed businesses can take advantage of government support, to the extent it does not duplicate NHS-funded income. However, concerns have been raised as to the level of government support for private dental businesses.
The BDA is currently lobbying government in relation to the cap on the Self-Employed Income Support Scheme, which restricts dentists earning over £50,000 through self-employed income from accessing any kind of support.
Concerns have also been raised about the lack of business interruption cover for businesses for the particular circumstances of CovidD-19. The Financial Conduct Authority (FCA) has stated many businesses will not be covered and is seeking a court declaration on behalf of policyholders to bring clarity. The BDA is seeking legal advice on behalf of its members.
Longer term financial considerations
In the longer term, fears exist for the future of many smaller dental businesses. A recent survey of BDA members, reported by the Times, suggested one in five dental businesses could close as a result of the financial impact of the pandemic.
According to the BDA's survey of 2,800 practices, 71.5% said they could stay "financially sustainable" for only three months at the most. More than one in five, 20.4%, said they would not survive beyond April. Mick Armstrong, BDA chair, said: "Practices are weeks from a cliff edge. Without meaningful support, the nation’s dental services face decimation."
David Houston said that for those dental businesses that survive it will take, on average, "three years of renewed trading in order to return to fee generating levels to pre-pandemic levels".
Some have argued that predominantly NHS funded business will have stronger financial security through uncertain times, as a result of the government support measures outlined above. The guaranteed levels of NHS income will be reassuring for those dental businesses albeit still somewhat unpredictable until the NHS has clarified financial expectations for the current financial year. The counterargument is that private dental businesses will be better able to be flexible and change their pricing, offerings and potentially longer opening hours.
Pinsent Masons has heard anecdotally that capitation payments remain strong, with a very small reduction in the number of patients. Houston said: "Those private dental businesses that have substantial capitation and payment plan patients will be in a significantly better cash flow position than their rivals." However, he admitted that this is based on the assumption that patients have "been willing to pay having 'missed' three months of service" and "isn’t compounded by many patients’ own financial circumstances". The economic crisis is expected to have an impact on consumer spending, which will test whether dentistry is seen as discretionary spend.
As part of the NHS contract reforms, some dental businesses have been trialling prototype contracts which blend traditional UDA delivery with a capitation payment. The guaranteed revenue stream afforded by the prototype contract may be seen as advantageous to a dental business in these uncertain times. However, it may also help on a service delivery perspective given the new and updated operating procedures require more time to decontaminate surgeries between patients.
Chris Aylward, chief investment officer of Riverdale Healthcare, said that the prototype contract "isn’t perfect but does allow the practice to manage patient needs in a more efficient way which could benefit businesses in the new world". We do not expect to see dental businesses rushing to convert their current NHS contracts to prototypes, but it does appear that the current situation gives the NHS a rare opportunity to accelerate adoption of the prototype or perhaps, even more radically, a wholesale replacement of the NHS contract, to meet with patient and regulatory demand.
Impact on M&A
Although a number of deals have completed during the lockdown period, the immediate prospects for M&A in the sector have been hit with many deals being put on hold and/or being re-evaluated to assess whether the target dental business and valuations remain aligned. However, as the dental market has seen a host of consolidation over recent years, M&A will remain a core component for many dental groups’ future strategy: indeed, we expect the post-pandemic market to be relatively active with smaller dental businesses looking to sell.
Simon Hughes, managing director for medical at Christie & Co, agrees. He said: "The market will find its level during the remainder of 2020 as the sector comes to terms with its new standard operating procedures and we see what effects, positive and negative, they will have on revenue and costs. Transactions will still continue in the second half of the year but those in the NHS sector are likely to be more fluid than the private sector."